Variation in responses to incretin therapy: Modifiable and non-modifiable factors.

Austin, Gregory O; Tomas, Alejandra

Austin, Gregory O; Tomas, Alejandra.

Afiliación

Austin GO; Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom.
Tomas A; Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom.

Front Mol Biosci ; 10: 1170181, 2023.

Article en En | MEDLINE | ID: mdl-37091864

Palabras clave

GIP (glucose-dependent insulinotropic polypeptide); GLP-1 (glucagon-like peptide-1); T2D (type 2 diabetes); incretin receptors; incretinbased therapy; obesity

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Mol Biosci Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google